Results 11 to 20 of about 3,369,625 (303)

Influence of perineural invasion in predicting overall survival and disease-free survival in patients With locally advanced gastric cancer [PDF]

open access: yes, 2017
Background The aim of the present study was to evaluate the prognostic significance of perineural invasion (PNI) in locally advanced gastric cancer patients who underwent D2 gastrectomy and adjuvant chemotherapy.
Aurello, P   +8 more
core   +1 more source

Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. [PDF]

open access: yes, 2011
BACKGROUND: Surgery is an important part of the management of oral cavity cancer with regard to both the removal of the primary tumour and removal of lymph nodes in the neck. Surgery is less frequently used in oropharyngeal cancer.
Bessell, A   +9 more
core   +3 more sources

Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011

open access: yesExperimental Hematology & Oncology, 2012
We present our initial experience of allogeneic stem cell transplant procedure performed between April 2004 and August 2011 for various haematological disorders.
Ali Natasha   +4 more
doaj   +1 more source

SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival [PDF]

open access: yes, 2017
Expression of the solute carrier (SLC) transporter SLC22A3 gene is associated with overall survival of pancreatic cancer patients. This study tested whether genetic variability in SLC22A3 associates with pancreatic cancer risk and prognosis.
Bambi, Franco   +40 more
core   +3 more sources

Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2021
The objectives of the study were to use tumor size data from 10 phase II/III atezolizumab studies across five solid tumor types to estimate tumor growth inhibition (TGI) metrics and assess the impact of TGI metrics and baseline prognostic factors on ...
Phyllis Chan   +10 more
doaj   +1 more source

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial [PDF]

open access: yes, 2019
Aprospective trial conducted in the period 2000-2005 showed no survival advantage for high-dose chemotherapy with rituximab and autograft (RHDS) versus conventional chemotherapy with rituximab (CHOP-R) as firstline therapy in 134 high-risk follicular ...
Angrilli, F.   +34 more
core   +4 more sources

Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer [PDF]

open access: yes, 2013
Background: Regulatory T cells (Treg) expressing the transcription factor forkhead-box protein P3 (Foxp3) have been identified to counteract anti-tumor immune responses during tumor progression. Besides, Foxp3 presentation by cancer cells itself may also
A Ho-Pun-Cheung   +45 more
core   +11 more sources

Systematic Survey of the Role of IGF in the Link Between Diabetes and Cancer [PDF]

open access: yes, 2018
Epidemiological studies have proposed a link between type II diabetes and cancer via the IGF/insulin signaling pathway, which includes insulin-like peptides (IGF1, IGF2, and insulin), insulin receptors (IR-A, IR-B, IGF1R, and hybrids), and insulin ...
Devanathan, Nirupama   +1 more
core   +2 more sources

Apalutamide and Overall Survival in Prostate Cancer

open access: yesEuropean Urology, 2021
The phase 3 SPARTAN study evaluated apalutamide versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) and prostate-specific antigen doubling time of ≤10 mo. At primary analysis, apalutamide improved median metastasis-free survival (MFS) by 2 yr and overall survival (OS) data were immature.We report the prespecified
Smith, Matthew R.   +17 more
openaire   +4 more sources

The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis

open access: yesCellular Physiology and Biochemistry, 2017
Aims: Growing evidence from recent studies has shown that lncRNA HULC plays a role in the development of multiple carcinomas. This meta-analysis aimed to analyze available data to identify the prognostic value of HULC in multiple tumors.
Xian Chen   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy